These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 33968425)
1. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer. Canbay E; Canbay Torun B; Cosarcan K; Altunal C; Gurbuz B; Bilgic C; Sezgin C; Kaban KK; Yilmaz S; Yazici Z J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S47-S56. PubMed ID: 33968425 [TBL] [Abstract][Full Text] [Related]
2. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy]. Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167 [No Abstract] [Full Text] [Related]
4. Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes. Read MD; Drake J; Hashemipour G; Powers BD; Mehta R; Sinnamon A; Pimiento JM; Dineen SP Ann Surg Oncol; 2024 Jun; 31(6):3750-3757. PubMed ID: 38430428 [TBL] [Abstract][Full Text] [Related]
5. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients. Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. van der Kaaij RT; Braam HJ; Boot H; Los M; Cats A; Grootscholten C; Schellens JH; Aalbers AG; Huitema AD; Knibbe CA; Boerma D; Wiezer MJ; van Ramshorst B; van Sandick JW JMIR Res Protoc; 2017 Jul; 6(7):e136. PubMed ID: 28705789 [TBL] [Abstract][Full Text] [Related]
7. Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience. Allievi N; Bianco F; Pisano M; Montori G; Fugazzola P; Coccolini F; Lotti M; Mosconi S; Merelli B; Campanati L; Lucianetti A; Ansaloni L; Magnone S Updates Surg; 2023 Jan; 75(1):159-167. PubMed ID: 36371549 [TBL] [Abstract][Full Text] [Related]
8. Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy. Kobiałka S; Sędłak K; Pelc Z; Mlak R; Endo Y; Bogacz P; Kurylcio A; Polkowski WP; Pawlik TM; Rawicz-Pruszyński K J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202168 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study. Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674 [TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy. Zhou S; Jiang Y; Liang J; Pei W; Zhou Z World J Surg Oncol; 2021 May; 19(1):151. PubMed ID: 34001125 [TBL] [Abstract][Full Text] [Related]
12. [Effects of laparoscopic hyperthermic intraperitoneal perfusion chemotherapy combined with intraperitoneal and systemic chemotherapy treatment in patients with untreated gastric cancer with peritoneal metastasis]. Li S; Xue K; Dai HM; Wang YK; Shan F; Li ZY; Ji JF Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):442-447. PubMed ID: 37217352 [No Abstract] [Full Text] [Related]
13. Perioperative intraperitoneal plus systemic chemotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gastric cancer: phase Ib/II single-arm prospective study. Cho M; Kim HS; Jung M; Hyung WJ J Gastrointest Surg; 2024 Jul; 28(7):1095-1103. PubMed ID: 38705369 [TBL] [Abstract][Full Text] [Related]
14. Review of management and treatment of peritoneal metastases from gastric cancer origin. Manzanedo I; Pereira F; Serrano Á; Pérez-Viejo E J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S20-S29. PubMed ID: 33968423 [TBL] [Abstract][Full Text] [Related]
15. Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central-Eastern European study. Yarema R; Mielko J; Fetsych T; Ohorchak M; Skorzewska M; Rawicz-Pruszyński K; Mashukov A; Maksimovsky V; Jastrzębski T; Polkowski W; Gyrya P; Kovalchuk Y; Safiyan V; Karelin I; Kopetskiy V; Kolesnik O; Kondratskiy Y; Paskonis M Cancer Med; 2019 Jun; 8(6):2877-2885. PubMed ID: 31033239 [TBL] [Abstract][Full Text] [Related]
16. Rationale of Treatment for Peritoneal Metastasis. Yonemura Y; Ishibashi H; Mizumoto A; Fujita T; Liu Y; Wakama S; Sako S; Takao N; Kitai T; Katayama K; Kamada Y; Taniguchi K; Fujimoto D Gan To Kagaku Ryoho; 2022 Dec; 49(13):1723-1726. PubMed ID: 36732979 [TBL] [Abstract][Full Text] [Related]
17. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis. Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases. Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614 [TBL] [Abstract][Full Text] [Related]
19. Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis. Buckarma E; Thiels CA; Jin Z; Grotz TE Ann Surg Oncol; 2024 Jan; 31(1):622-629. PubMed ID: 37880514 [TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review. Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]